Tilray Inc
Drug Manufacturers - Specialty & Generic
Healthcare
TLRY
908 M shares
NASDAQ US
traded
29 Aug 2025
listed
no
open
1.44
52 week high
2.85
high
1.46
52 week low
0.00
low
1.36
growth
-19.30 %
previous Close
1.47
P/E ratio
market cap
554 M
div yield
0
usd
May 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
424.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top top